NCT00494611View on ClinicalTrials.gov

A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Colon Cancer
Interventions
DRUG

Peri operative Cetuximab.

Cetuximab will be given immediately preoperative and early post surgery period.

Trial Locations (1)

10019

St Luke's Roosevelt Medical Center, New York

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

St. Luke's-Roosevelt Hospital Center

OTHER

NCT00494611 - A Study of the Perioperative Use of Cetuximab in Colon Cancer Patients | Biotech Hunter | Biotech Hunter